Neurostimulation company Checkpoint Surgical has raised a $1.7 million series B round of investment and expects to win European regulatory approval of its intraoperative device shortly.
The Cleveland-area company will use the new funding to boost its U.S. sales and marketing staff, CEO Len Cosentino said.
The company’s handheld, disposable device, called the Checkpoint Stimulator/Locator, stimulates motor nerves so surgeons can avoid damaging them during surgery....
Read the complete story.